Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors
Open Access
- 14 January 2005
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (4) , 341-349
- https://doi.org/10.1038/sj.cgt.7700801
Abstract
A long-pursued goal in cancer treatment is to deliver a therapy specifically to metastases. As a result of the disseminated nature of the metastatic disease, carrying the therapeutic agent to the sites of tumor growth represents a major step for success. We hypothesized that tumor cells injected intravenously (i.v.) into an animal with metastases would respond to many of the factors driving the metastatic process, and would target metastases. Using a model of spontaneous metastases, we report here that i.v. injected tumor cells localized on metastatic lesions. Based on this fact, we used genetically transduced tumor cells for tumor targeting of anticancer agents such as a suicide gene or an oncolytic virus, with evident antitumoral effect and negligible systemic toxicity. Therefore, autologous tumor cells may be used as cellular vehicles for systemic delivery of anticancer therapies to metastatic tumors.Keywords
This publication has 18 references indexed in Scilit:
- Cells as Vehicles for Cancer Gene Therapy: The Missing Link Between Targeted Vectors and Systemic Delivery?Human Gene Therapy, 2002
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Combination bacteriolytic therapy for the treatment of experimental tumorsProceedings of the National Academy of Sciences, 2001
- Improving the efficacy of antibody-based cancer therapiesNature Reviews Cancer, 2001
- Integrin activation controls metastasis in human breast cancerProceedings of the National Academy of Sciences, 2001
- Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomasProceedings of the National Academy of Sciences, 2000
- Use of preferentially replicating bacteria for the treatment of cancerJournal of Clinical Investigation, 2000
- Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasisNature Medicine, 2000
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sitesCancer and Metastasis Reviews, 1988